ATC/DDD

ATC/DDD index J01MA

You are here: Home > ATC/DDD > J > J01 > J01M

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- J
ANTIINFECTIVES FOR SYSTEMIC USE
- J01
ANTIBACTERIALS FOR SYSTEMIC USE
- J01M
QUINOLONE ANTIBACTERIALS

J01MA

Fluoroquinolones

ATC/DDD code J01MA for Fluoroquinolones

Flumequine is classified in J01MB.

The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.

The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.

J01MA01
Ofloxacin
J01MA02
Ciprofloxacin
J01MA03
Pefloxacin
J01MA04
Enoxacin
J01MA05
Temafloxacin
J01MA06
Norfloxacin
J01MA07
Lomefloxacin
J01MA08
Fleroxacin
J01MA09
Sparfloxacin
J01MA10
Rufloxacin
J01MA11
Grepafloxacin
J01MA12
Levofloxacin
J01MA13
Trovafloxacin
J01MA14
Moxifloxacin
J01MA15
Gemifloxacin
J01MA16
Gatifloxacin
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us